PharmaShots Weekly Snapshot (February 03-07, 2020)

1. WHO to Accelerate Global Research and Innovation Against Corona Virus

Published: Feb 06, 2020 | Tags: WHO, Accelerate, Global, Research, Innovation, Against, Corona Virus

2.  Curis Amends its Existing Collaboration with Aurigene for the Development and Commercialization of CA-170

Published: Feb 07, 2020 | Tags: Curis, Amends, Existing Collaboration, Aurigene, Development, Commercialization, CA-170

3.  Novo Nordisk to Invest ~$117.4M in Expansion of its Production Facilities in Denmark

Published: Feb 07, 2020 | Tags: Novo Nordisk, Invest, ~$117.4M, Expansion, Production Facilities, Denmark

4.  Collegium to Acquire US Rights of Assertio’s Nucynta Franchise for $375M

Published: Feb 06, 2020 | Tags: Collegium, Acquire, US, Rights, Assertio, Nucynta Franchise, $375M

5.  Merck & Co. to Initiate P-II Study of MK-5890 for Non-Small Cell Lung Cancer

Published: Feb 06, 2020 | Tags: Merck & Co., Initiates, P-II, Study, MK-5890, Non-Small Cell Lung Cancer

6. Roche Reports Results of Tecentriq (atezolizumab) + Avastin (bevacizumab) in P-III IMbrave150 Study in Chinese Patients with Hepatocellular Carcinoma

Published: Feb 07, 2020 | Tags: Roche, Reports, Results, Tecentriq, atezolizumab, Avastin, bevacizumab, P-III, IMbrave150 Study, Chinese Patients, Hepatocellular Carcinoma

7. Almirall Collaborates with Plug and Play to Offer Digital Solutions in Dermatology

Published: Feb 06, 2020 | Tags: Almirall, Collaborates, Plug and Play, Offer, Digital Solutions, Dermatology

8. Bridge Biotherapeutics Signs a License Agreement with Konkuk University for its Back-Eye Disease Therapy

Published: Feb 06, 2020 | Tags: Bridge Biotherapeutics, Signs, License Agreement, Konkuk University, Back-Eye Disease Therapy

9. Nestle Health Science Signs a Worldwide Exclusive Agreement with VALBIOTIS to Develop and Commercialize TOTUM-63 for Reducing the Risk of T2D

Published:  Feb 05, 2020 | Tags: Nestle Health Science, Signs, Worldwide, Exclusive Agreement, VALBIOTIS, Develop, Commercialize, TOTUM-63, Reducing, T2D

10. Roche Reports Results of Risdiplam in SUNFISH Part 2 Study for Patients with Type 2 Or 3 Spinal Muscular Atrophy

Published: Feb 06, 2020 | Tags: Roche, Reports, Results, Risdiplam, SUNFISH Part 2, Study, Patients, Type 2 Or 3, Spinal Muscular Atrophy

11.  Fresenius Kabi Reports the Availability of Glucagon Emergency Medicine Kit to Treat Hypoglycemia in the US

Published: Feb 05, 2020 | Tags: Fresenius Kabi, Reports, Availability, Glucagon Emergency Medicine Kit, Hypoglycemia, US

12.  Sanofi Reports Results of SAR442168 in P-IIb Study for Relapsing Multiple Sclerosis

Published: Feb 06, 2020 | Tags: Sanofi, Reports, Results, SAR442168, P-IIb, Study, Relapsing Multiple Sclerosis

13. Merck & Co. Collaborates with Atreca to Identify Novel Antibody Targets in Oncology

Published: Feb 05, 2020 | Tags: Merck & Co., Collaborates, Atreca, Identify, Novel Antibody Targets, Oncology

14. Johnson & Johnson Initiates the Development of Vaccines Against Coronavirus

Published: Feb 06, 2020 | Tags: Johnson & Johnson, Initiates, Development, Vaccines, Coronavirus

15. Alector’s AL101 Receives FDA’s Fast Track Designation to Treat Frontotemporal Dementia

Published: Feb 05, 2020 | Tags: Alector, AL101, Receives, FDA, Fast Track Designation, Treat, Frontotemporal Dementia

16. Navrogen and Levena Collaborate to Develop ADCs for Humoral Immuno-Suppressed Cancers

Published: Feb 05, 2020 | Tags:  Navrogen, Levena, Collaborate, ADCs, Humoral Immuno-Suppressed Cancers

17. Seqirus’ Audenz Receives the US FDA’s Approval as the First Adjuvanted Cell-Based Pandemic Influenza A (H5N1) Vaccine

Published: Feb 03, 2020 | Tags: Seqirus, Audenz, Receives, US, FDA, Approval, First, Adjuvanted, Cell-Based, Pandemic, Influenza A, H5N1 Vaccine

18. Merck & Co. to Spin-Off its Non-Core Business into a New Company to Focus on its Core Therapy Areas

Published: Feb 05, 2020 | Tags: Merck, Spin -Off, Non-Core Business, New Company, Core Therapy Areas

19. The US FDA Grants Emergency Use Authorization for Coronavirus Diagnostic Test

Published: Feb 04, 2020 | Tags: US, FDA, Grants, Emergency Use Authorization, Coronavirus Diagnostic Test

20. AbbVie’s Rinvoq (upadacitinib) Receives ANVISA’s Approval for Rheumatoid Arthritis

Published: Feb 04, 2020 | Tags: AbbVie, Rinvoq, upadacitinib, Receives, ANVISA, Approval, Rheumatoid Arthritis

21. BioMotiv and BMS to Launch Anteros Pharmaceuticals

Published: Feb 05, 2020 | Tags: BioMotiv, BMS, Launch, Anteros Pharmaceuticals

22. Regeneron Expands its Existing Collaboration with HHS’BARDA to Develop Antibody Therapies for Coronavirus

Published: Feb 04, 2020 | Tags: Regeneron, Expands, Existing Collaboration, HHS, BARDA, Develop, Antibody Therapies, Coronavirus

23. GSK Reports EMA’s Acceptance of MAA for Belantamab Mafodotin to Treat Relapsed or Refractory Multiple Myeloma

Published: Feb 04, 2020 | Tags: GSK, Reports, EMA, Acceptance, MAA, Belantamab Mafodotin, Treat, Relapsed or Refractory, Multiple Myeloma

24. CELLINK Expands its Multi-Target Collaboration with AstraZeneca for Drug Discovery

Published: Feb 04, 2020 | Tags: CELLINK, Expands, Multi-Target, Collaboration, AstraZeneca, Drug Discovery

25. Boehringer Ingelheim Reports Real-World Data for Spiriva Respimat (tiotropium bromide) Inhalation Spray 1.25mcg in Patients with Asthma

Published: Feb 04, 2020 | Tags: Boehringer Ingelheim, Reports, Real-World Data, Spiriva Respimat, (tiotropium bromide), Inhalation Spray, 1.25mcg, Patients, Asthma

26. Kyowa Kirin Terminates its Agreement with Zeria Pharmaceuticals for ASACOL (mesalazine)

Published: Feb 04, 2020 | Tags: Kyowa Kirin, Terminates, Agreement, Zeria Pharmaceuticals, ASACOL, (mesalazine)

27. Bio-Thera Reports Results of BAT1706 (biosimilar, bevacizumab) in P-III Trial for Patients with Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Published: Feb 04, 2020 | Tags: Bio-Thera, Reports, Results, BAT1706, biosimilar, bevacizumab, P-III, Non-Squamous Non-Small Cell Lung Cancer, NSCLC

28. IMIDomics Collaborates with Gossamer Bio to Develop Therapies for Treating Immune-Mediated Inflammatory Diseases

Published: Feb 04, 2020 | Tags: IMIDomics, Collaborates, Gossamer Bio, Develop, Therapies, Treating, Immune-Mediated Inflammatory Diseases

29. Danaher Receives S.Korean FTC’s Conditional Approval for its $21.4B GE Biopharma Acquisition

Published: Feb 04, 2020 | Tags: Danaher, Receives, S.Korean FTC, Conditional Approval, $21.4B, GE Biopharma Acquisition

30. Amgen Launches Amgevita (biosimilar, adalimumab) for the Treatment of Inflammatory Diseases in Brazil

Published: Feb 03, 2020 | Tags: Amgen, Launches, Amgevita, biosimilar, adalimumab, Treatment, Inflammatory Diseases, Brazil

31. Pfizer’s Ruxience (biosimilar, rituximab) Receives CHMP’s Positive Opinion for Cancer and Autoimmune Diseases

Published: Jan 31, 2020 | Tags: Pfizer, Ruxience, biosimilar, rituximab, Receives, CHMP, Positive Opinion, Cancer, Autoimmune Diseases

32. Teva Reports Results of Ajovy (fremanezumab) in Two P-II/III Clinical Studies for the Treatment of Migraine in Japan

Published: Feb 03, 2020 | Tags: Teva, Reports, Results, Ajovy, fremanezumab, Two, P-II/III, Clinical Studies, Treatment, Migraine, Japan

33. GSK Collaborates with CEPI to Develop Vaccine Against Corona Virus

Published: Feb 03, 2020 | Tags: GSK, Collaborates, CEPI, Develop, Vaccine, Against, Corona Virus

34. Eli Lilly Launches Reyvow (lasmiditan) C-V for the Treatment of Migraine in the US

Published: Feb 03, 2020 | Tags: Eli Lilly, Launches, Reyvow, lasmiditan, C-V, Treatment, Migraine, US